With the supply of Paxlovid being a problem as noted in the article, and should Apabetalone proves to be successful in the next couple of months, this may give us the cover we need to announce a competitive Canadian therapeutic that is anti-viral, and anti-inflammatory. The timing couldn't be any better.
Koo